Detalles de la búsqueda
1.
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.
Lancet
; 402(10405): 871-881, 2023 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37478883
2.
Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.
Cancer
; 129(17): 2685-2693, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37129197
3.
Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial.
Lancet Oncol
; 23(10): 1321-1331, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36087590
4.
Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients With Advanced Lung Cancer: A Comparative Retrospective Cohort Study.
Clin Infect Dis
; 73(9): e2697-e2704, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32564081
5.
Pattern and Predictors of Outpatient Palliative Care Referral Among Thoracic Medical Oncologists.
Oncologist
; 23(10): 1230-1235, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29895629
6.
Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors.
Invest New Drugs
; 34(3): 290-9, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26961907
7.
Mutational characteristics and clinical outcomes for lung adenocarcinoma with EGFR germline mutations.
J Thorac Oncol
; 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38866326
8.
Longitudinal associations between caregiver burden and patient and spouse distress in couples coping with lung cancer.
Support Care Cancer
; 21(9): 2371-9, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23546537
9.
Integration of Remote Symptom and Biometric Monitoring Into the Care of Adult Patients With Cancer Receiving Chemotherapy-A Decentralized Feasibility Pilot Study.
JCO Oncol Pract
; 19(6): e811-e821, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36821818
10.
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy.
J Clin Oncol
; 41(15): 2682-2690, 2023 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37196429
11.
Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC.
JTO Clin Res Rep
; 4(8): 100533, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37649681
12.
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
Nat Med
; 29(3): 593-604, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36928818
13.
Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial.
J Clin Oncol
; 40(7): 702-709, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34550757
14.
Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer.
Cancer Treat Res Commun
; 30: 100514, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35051703
15.
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial.
Lung Cancer
; 174: 112-117, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36371941
16.
Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity.
Cancer Cell
; 40(7): 754-767.e6, 2022 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35820397
17.
Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling.
JCO Precis Oncol
; 52021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34377884
18.
Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC.
J Thorac Oncol
; 16(2): 269-277, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33198942
19.
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial.
Radiother Oncol
; 162: 60-67, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237343
20.
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
Nat Med
; 27(3): 504-514, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33603241